The Clinical Times
The Front Page of Medicine

Recalls & Safety · page 5

Recalls and safety alerts from the FDA, newest first.

FDA Drugs · Jul 24, 2026

BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION

July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard. Risk Statement: The use of the defective product has a

FDA Recalls · Jul 24, 2026

American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter

July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level. The product is being recalled due to the presence of particulate matter identified as glass an

FDA Enforcement · Jul 22, 2026

Drug recall: Clinere, Carbamide Peroxide

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). — Bell Pharmaceuticals, Inc · Class II · Ongoing · 29, 474 units

← NewerOlder →

Back to the live front page